Healthcare
Live Price
Offline$4.00
+0.00% today
1Y Change
+35.38%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 251 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
WuXi Biologics (Cayman) Inc. (WXIBF) is a Healthcare stock with a market cap of $124.50B and listed on OTC. The stock last traded around $4.00 and up 35.4% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +13.7%, EPS growth of +45.1%, a dividend yield of 0.0%. What stands out right now is revenue +13.7%, EPS +45.1%, free cash flow +117.4% with operating margin 30.5% and ROIC 9.2%. Valuation sits in the middle of the pack at P/E 24.6 and price/sales 5.8. Stock Foundry combines WXIBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WXIBF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WXIBF Max Drawdown
-30.43%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WXIBF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.